Search Legislation

Council Regulation (EEC) No 2377/90 (repealed)Show full title

Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)

 Help about what version

What Version

 Help about advanced features

Advanced Features

More Resources

Revised version PDFs

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

Point in time view as at 20/03/2005.

Changes to legislation:

There are currently no known outstanding effects for the Council Regulation (EEC) No 2377/90 (repealed), Division 1. . Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

[F11. Anti-infectious agents U.K.

1.1. Chemotheurapeutics U.K.

1.1.2. Benzenesulphonamides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clorsulon Clorsulon Bovine 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
150 μg/kg Liver
400 μg/kg Kidney

1.2. Antibiotics U.K.

1.2.1. Beta-lactamase inhibitors U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clavulanic acid Clavulanic acid Bovine, ovine 200 μg/kg Milk [F2Provisional MRLs expire on 1 July 2001]
Bovine, ovine, porcine 200 μg/kg Muscle
200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
1.2.2. Macrolides U.K.
a

[F3Provisional MRLs expire on 1 July 2006 .

b

Not for use in animals from which eggs are produced for human consumption.]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F4Acetylisovaleryltylosin Sum of acetylisovaleryltylosin and 3-O-acetyltylosin Porcine 100 μg/kg Muscle Provisional MRLs expire on 1.7.2001
100 μg/kg Skin and fat
100 μg/kg Liver
100 μg/kg Kidney]
[F3Acetylisovaleryltylosin a Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin Poultry b 50 μg/kg Skin and fat
50 μg/kg Liver ]
Erythromycin MRLs apply to all microbiological active residues expressed as erythromycin equivalent Bovine, ovine 40 μg/kg Milk Provisional MRLs expire on 1 June 2000
Bovine, ovine, porcine, poultry 400 μg/kg Muscle
400 μg/kg Fat
400 μg/kg Liver
400 μg/kg Kidney
Poultry 200 μg/kg Eggs
Josamycin Josamycin Chicken 200 μg/kg Muscle [F5Provisional MRLs expire on 1.7.2002]
200 μg/kg Fat
200 μg/kg Liver
400 μg/kg Kidney
200 μg/kg Eggs
[F6 Sum of the microbiologically active metabolites, expressed as josamycin Porcine 200 μg/kg Muscle Provisional MRLs expire on 1.7.2002
200 μg/kg Skin and fat
200 μg/kg Liver
400 μg/kg Kidney]
[F7Tilmicosin Tilmicosin Bovine 40 μg/kg Milk Provisional MRLs expire on 1.1.2001]
[F8Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2- ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa- 6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine 100 μg/kg Fat Provisional MRLs expire on 1 July 2004 ; not for use in animals from which milk is produced for human consumption
3 000  μg/kg Liver
3 000  μg/kg Kidney
Porcine 100 μg/kg Skin and fat Provisional MRLs expire on 1 July 2004
3 000  μg/kg Liver
3 000  μg/kg Kidney]

Textual Amendments

[F91.2.4. Cephalosporins U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cefacetrile Cefacetrile Bovine 125 μg/kg Milk

[F10Provisional MRLs expire on 1.1.2002]

For intrammamary use only

[F11Cefalonium Cefalonium Bovine 10 μg/kg Milk [F12Provisional MRLs expire on 1.1.2003] ]
[F13Cefoperazone Cefoperazone Bovine 50 μg/kg Milk Provisional MRLs expire on 1 January 2001]
[F14Cefquinome Cefquinome Porcine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2000
50 μg/kg Skin + fat
100 μg/kg Liver
200 μg/kg Kidney]
Cephapirin Sum of cephapirin and desacetylcephapirin Bovine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
50 μg/kg Liver
100 μg/kg Kidney
10 μg/kg Milk]

Textual Amendments

1.2.5. Aminoglycosides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Aminosidine Aminosidine Bovine, porcine, rabbits, chicken 500 μg/kg Muscle Provisional MRLs expire on 1 July 2000
1 500  μg/kg Liver
1 500  μg/kg Kidney
Apramycin Apramycin Bovine 1 000  μg/kg Muscle Provisional MRLs expire on 1 July 1999
For use in non-lactating cattle only 1 000  μg/kg Fat
10 000  μg/kg Liver
20 000  μg/kg Kidney
Porcine 1 000  μg/kg Muscle
1 000  μg/kg Skin and fat
1 000  μg/kg Liver
5 000  μg/kg Kidney
[F15Dihydrostreptomycin Dihydrostreptomycin Bovine, ovine 500 μg/kg Muscle Provisional MRLs expire on 1.6.2002
500 μg/kg Fat
500 μg/kg Liver
1 000  μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin and fat
500 μg/kg Liver
1 000  μg/kg Kidney
Gentamicin Gentamicin Bovine 100 μg/kg Milk Provisional MRLs expire on 1.6.2002
Bovine, porcine 50 μg/kg Muscle
50 μg/kg Fat
200 μg/kg Liver
750 μg/kg Kidney]
[F16Kanamycin Kanamycin Rabbits 100 μg/kg Muscle [F17Provisional MRLs expire on 1.1.2004]
100 μg/kg Fat
600 μg/kg Liver
2 500  μg/kg Kidney
Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
600 μg/kg Liver
2 500  μg/kg Kidney
150 μg/kg Milk
Porcine, chicken 100 μg/kg Muscle
100 μg/kg Skin + fat
600 μg/kg Liver
2 500  μg/kg Kidney]
[F15Neomycin (including framycetin) Neomycin B Bovine, porcine, chicken 500 μg/kg Muscle Provisional MRLs expire on 1.6.2002
500 μg/kg Fat
500 μg/kg Liver
5 000  μg/kg Kidney
Bovine 500 μg/kg Milk
Chicken 500 μg/kg Eggs]
Spectinomycin Spectinomycin Bovine 200 μg/kg Milk Provisional MRLs expire on 1 July 2000
Bovine, porcine, poultry 300 μg/kg Muscle
500 μg/kg Fat
2 000  μg/kg Liver
5 000  μg/kg Kidney
[F11

Ovine

Not for use in animals from which milk is produced for human consumption

300 μg/kg Muscle Provisional MRLs expire on 1.1.2002
500 μg/kg Fat
2 000  μg/kg Liver
5 000  μg/kg Kidney
Chicken 200 μg/kg Eggs]
[F15Streptomycin Streptomycin Bovine, ovine 500 μg/kg Muscle Provisional MRLs expire on 1.6.2002
500 μg/kg Fat
500 μg/kg Liver
1 000  μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin and fat
500 μg/kg Liver
1 000  μg/kg Kidney]
1.2.6. Quinolones U.K.
a

[F18Provisional MRLs expire 1 January 2006 .

b

Not for use in animals from which milk is produced for human consumption.]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F6Danofloxacin Danofloxacin Porcine 100 μg/kg Muscle Provisional MRLs expire on 1.1.2000
50 μg/kg Skin and fat
200 μg/kg Liver
200 μg/kg Kidney]
Decoquinate Decoquinate Bovine, ovine 500 μg/kg Muscle Provisional MRLs expire on 1 July 2000
500 μg/kg Fat
500 μg/kg Liver
500 μg/kg Kidney
[F19Difloxacin Difloxacin

Bovine

Not for use in animals from which milk is produced for human consumption

400 μg/kg Muscle Provisional MRLs expire on 1.1.2001
100 μg/kg Fat
1 400 μg/kg Liver
800 μg/kg Kidney
Porcine 400 μg/kg Muscle
100 μg/kg Skin and fat
800 μg/kg Liver
800 μg/kg Kidney]
Enrofloxacin Sum of enrofloxacin and ciprofloxacin Ovine 100 μg/kg Muscle Provisional MRLs expire on 1 July 1999
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
Flumequine Flumequine Bovine, ovine, porcine, chicken 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
50 μg/kg Fat or skin and fat
100 μg/kg Liver
300 μg/kg Kidney
Salmonidae 150 μg/kg Muscle and skin
Marbofloxacin Marbofloxacin Bovine 150 μg/kg Muscle Provisional MRLs expire on 1 July 2000
50 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
75 μg/kg Milk
Porcine 150 μg/kg Muscle
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
[F9 [F20Oxolinic acid a Oxolinic acid Bovine b 100 µg/kg Muscle
50 µg/kg Fat
150 µg/kg Liver
150 µg/kg Kidney]
Porcine 100 μg/kg Muscle
50 μg/kg Skin + fat
150 μg/kg Liver
150 μg/kg Kidney
Chicken 100 μg/kg Muscle
50 μg/kg Skin + fat
150 μg/kg Liver
150 μg/kg Kidney
50 μg/kg Eggs
Fin fish 300 μg/kg Muscle and skin in natural proportions]
1.2.9. Polymyxins U.K.
Phamarcologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Colistin Colistin Bovine, ovine 50 μg/kg Milk [F5Provisional MRLs expire on 1.7.2002]
Bovine, ovine, porcine, chicken, rabbits 150 μg/kg Muscle
150 μg/kg Fat
150 μg/kg Liver
200 μg/kg Kidney
Chicken 300 μg/kg Eggs
1.2.10. Penicillins U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F9Nafcillin Nafcillin Bovine 300 μg/kg Muscle Provisional MRLs expire on 1.1.2001
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk]
Penethamate Benzylpenicillin Ovine 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Porcine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
1.2.11. Florfenicol and related compounds U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Florfenicol Sum of florfenicol and its metabolites measured as florfenicol-amine Fish 1 000  μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1 July 2001
[F9Thiamphenicol Thiamphenicol Ovine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
Porcine 50 μg/kg Muscle
50 μg/kg Skin + fat
50 μg/kg Liver
50 μg/kg Kidney
Fin fish 50 μg/kg Muscle and skin in natural proportions]
[F61.2.12. Polypeptides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Bacitracin Bacitracin Bovine 150 μg/kg Milk Provisional MRLs expire on 1.7.2001]
[F91.2.13. Lincosamides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Lincomycin Lincomycin Ovine 100 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
500 μg/kg Liver
1 500 μg/kg Kidney
150 μg/kg Milk
Porcine 100 μg/kg Muscle
50 μg/kg Skin + fat
500 μg/kg Liver
1 500 μg/kg Kidney
Chicken 100 μg/kg Muscle
50 μg/kg Skin + fat
500 μg/kg Liver
1 500 μg/kg Kidney
50 μg/kg Eggs
[F6Pirlimycin Pirlimycin Bovine 100 μg/kg Muscle Provisional MRLs expire on 1.7.2000
100 μg/kg Fat
1 000 μg/kg Liver
400 μg/kg Kidney
100 μg/kg Milk] ]
[F111.2.14. Pleuromutilines U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Tiamulin Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin Turkey 100 μg/kg Muscle Provisional MRLs expire on 1.7.2001
100 μg/kg Skin and fat
300 μg/kg Liver] ]

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources